Global Cartilage repair market

Cartilage Repair Market Size, Share, Growth Analysis, By Treatment Modality(Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds), By Application(Knee, Hip, Ankle and Foot, and Other Application Sites), By Application site(Hyaline Cartilage, Fibrocartilage), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35D2072 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 121 | Figures: 77

Cartilage Repair Market Insights

Cartilage Repair Market size was valued at USD 1.25 Billion in 2023 and is poised to grow from USD 1.46 Billion in 2024 to USD 5.12 Billion by 2032, growing at a CAGR of 17% during the forecast period (2025-2032).

The global cartilage repair industry is witnessing significant growth driven by growing incidence of conditions such as osteoarthritis (OA) and arthritis, in conjunction with advancements in cartilage regeneration technologies. Other factors enhancing the incidence of OA include intensifying effects of obesity and other associated conditions, combined with growing elderly populations. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 billion Americans, or 10.5% of the population, have diabetes. Apart from this, growth in the market will be driven by smart devices and further technical developments, such as artificial intelligence and data analytics. The expanding prevalence of diabetes and obesity across the world will continue to drive the global cartilage repair market growth. Increasing obesity is going to fuel the need for cartilage repair products, in particular, for the Latin America and MEA region is expected to have growing markets. Indeed, as related by the American Heart Association (AHA), by 2030, the elderly will comprise approximately 40.0% of the world's population. As individuals are predicted to suffer from chronic diseases, this population will have huge demand generation for cartilage repair therapies and propel the market growth.

US Cartilage Repair Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cartilage Repair Market size was valued at around USD 1 billion in 2022 and is expected to rise from USD 1.25 billion in 2023 to reach a value of USD 4.38 billion by 2031, at a CAGR of 17% over the forecast period (2024–2031).

The cartilage repair market is highly competitive and has matured firms as well as new biotech firms. The smaller businesses have been focusing on advanced regenerative medicines, such as tissue engineering and stem cell-based therapies. Growth strategies through strategic alliances, mergers, and ongoing research and development form the majority dynamics for the market.  'DePuy Synthes (Johnson & Johnson) ', 'Zimmer Biomet Holdings Inc. ', 'Smith & Nephew plc ', 'Vericel Corporation ', 'Osiris Therapeutics Inc. ', 'Histogenics Corporation ', 'Anika Therapeutics Inc ', 'Arthrex Inc. ', 'B. Braun Melsungen AG ', 'Stryker Corporation ', 'CONMED Corporation ', 'Orthocell Limited ', 'RTI Surgical Holdings Inc. ', 'MEDIPOST Co. Ltd. ', 'CellGenix GmbH ', 'Tissue Regenix Group plc ', 'CollPlant Biotechnologies Ltd. ', 'ISTO Technologies Inc. ', 'MTF Biologics ', 'CartiHeal Ltd.'

The most common patients requiring knee cartilage repair surgery are young people who have suffered injuries in the knee joint, such as meniscal or ligament tears. Damaged cartilage is repaired using methods that include cell-based cartilage resurfacing and autologous chondrocyte implantation to hasten the formation of new cartilage in joints. It delays and prevents the occurrence of arthritis, which also greatly reduces joint pain and increases joint flexibility through repairing and replacing the cartilage. 

Minimally Invasive Techniques: More and more, patients seek therapies that allow rapid recovery, less morbidity, and less pain after surgery. The success of restoring cartilage effectively with fewer incisions and rapid recovery is what appeals to procedures such as arthroscopy, biologic injections (PRP, stem cells), and microfracture surgery. Those techniques will eventually supplant more invasive and traditional operations as they continue to evolve. 

In 2023, North America was established as the market leader, commanding a share of over 45%. If people choose a healthy lifestyle, the forecast till at least the end of the review period is for the region to maintain its leading position. The urge for and appeal of cartilage repair in the United States and Canada is largely driven by a target audience and shifts in lifestyles, combined with the ever-increasing rate of musculoskeletal disorders. Further, the incidence of osteoporosis in the UK, Germany, and France is increasing significantly, and about 500,000 people require hospital care each year due to fractures at standing height or below caused by osteoporosis. It is expected to affect the Europe market. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cartilage repair market

Report ID: SQMIG35D2072

$5,300
BUY NOW GET FREE SAMPLE